We are live on ! Find out more
CATX icon

Perspective Therapeutics
CATX

49 hedge funds and large institutions have $9.99M invested in Perspective Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.12% more ownership

Funds ownership: 1.18% → 1.3% (+0.12%)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

2% less funds holding

Funds holding: 50 → 49 (-1)

17% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 12

55% less capital invested

Capital invested by funds: $22M → $9.99M (-$12M)

Holders
49
Holders Change
-1
Holders Change %
-2%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
10
Reduced
12
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$2.48M
2
Jane Street
Jane Street
New York
+$62.8K
3
HF
HRT Financial
New York
+$47.9K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$46.3K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$31.2K

Top Sellers

Rank Fund Capital Flow
1
PIC
Portland Investment Counsel
Ontario, Canada
-$683K
2
BlackRock
BlackRock
New York
-$373K
3
Citadel Advisors
Citadel Advisors
Florida
-$111K
4
Renaissance Technologies
Renaissance Technologies
New York
-$32.3K
5
Cerity Partners
Cerity Partners
New York
-$26.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Advisers
26
Two Sigma Advisers
New York
$8.92K -$1.68K -360 -10%
LPL Financial
27
LPL Financial
California
$7.3K -$3.49K -748 -22%
TWM
28
TMD Wealth Management
Arizona
$5.47K – – –
WAOI
29
Wealth Advisors of Iowa
Iowa
$5.47K – – –
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$5.29K +$1.34K +287 +17%
Fidelity Investments
31
Fidelity Investments
Massachusetts
$4.93K +$8.39K +1,797 +59,900%
RJFSA
32
Raymond James Financial Services Advisors
Florida
$4.79K -$467 -100 -5%
Ameriprise
33
Ameriprise
Minnesota
$4.11K – – –
MFG
34
Mendota Financial Group
Wisconsin
$4.11K – – –
CWM
35
Congress Wealth Management
Massachusetts
$4.11K – – –
KL
36
KilterHowling LLC
Colorado
$4K – – –
TRCT
37
Tower Research Capital (TRC)
New York
$3.85K +$1.32K +283 +25%
Goldman Sachs
38
Goldman Sachs
New York
$3.66K +$6.24K +1,337 New
GVAG
39
Great Valley Advisor Group
Delaware
$3.28K – – –
VF
40
Virtu Financial
New York
$3K +$5.94K +1,273 New
AAM
41
Auxier Asset Management
Oregon
$2.8K – – –
CAI
42
Capital Advisors Inc
Oklahoma
$2.74K – – –
JFA
43
JNBA Financial Advisors
Minnesota
$1.37K – – –
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$1K +$919 +197 +758%
TWC
45
TD Waterhouse Canada
Ontario, Canada
$528 – – –
UBS Group
46
UBS Group
Switzerland
$186 -$75 -16 -19%
CCM
47
Chilton Capital Management
Texas
$137 – – –
JP Morgan Chase
48
JP Morgan Chase
New York
$90 +$154 +33 New
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
$10 – – –
PIC
50
Portland Investment Counsel
Ontario, Canada
– -$683K -103,410 Closed
1
2
3

CATX Hedge Fund Activity: Q3 2023 in Review

49 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q3 2023, worth a combined $9.99M — down 55% from $22M a quarter earlier.

Fund positioning in CATX was balanced in Q3 2023: 4 funds opened new positions, 4 closed out, 10 added to existing stakes and 12 trimmed.

The largest buyer was Baker Bros. Advisors, adding an estimated $2.48M. The largest seller was Portland Investment Counsel, exiting entirely with an estimated $683K sold.

  • 49 institutional investors held Perspective Therapeutics (CATX) as of Q3 2023, down from 50 in Q2 2023.
  • Funds reported $9.99M of Perspective Therapeutics stock for Q3 2023, down 55% quarter-over-quarter.
  • 4 funds opened new Perspective Therapeutics positions in Q3 2023 and 4 closed out, a net change of 0 holders.
  • The largest Perspective Therapeutics buyer in Q3 2023 was Baker Bros. Advisors, an estimated $2.48M added.
  • The largest Perspective Therapeutics seller in Q3 2023 was Portland Investment Counsel, an estimated $683K sold.

Based on aggregated 13F filings for Q3 2023.